Evidence map›Paper›PMID 29425164›Full record

ArticleMarine drugs2018

Association of Alpha Tocopherol and Ag Sulfadiazine Chitosan Oleate Nanocarriers in Bioactive Dressings Supporting Platelet Lysate Application to Skin Wounds.

Maria Cristina Bonferoni, Giuseppina Sandri, Silvia Rossi, Eleonora Dellera, Alessandro Invernizzi, Cinzia Boselli, Antonia Icaro Cornaglia, Claudia Del Fante, Cesare Perotti, Barbara Vigani and 3 more

Open access · goldAbstract read
In one paragraph

Article in Marine drugs, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. New Nanotechnologies for the Treatment and Repair of Skin Burns Infections.International journal of molecular sciences · 2020
    Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Maria Cristina BonferoniDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy. cbonferoni@unipv.it.
Giuseppina SandriDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy. giuseppina.sandri@unipv.it.ORCID 0000-0001-6766-9321
Silvia RossiDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy. silvia.rossi@unipv.it.ORCID 0000-0001-9511-3857
Eleonora DelleraDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy. Eleonora.Dellera@bouty.it.
Alessandro InvernizziDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy. alessandro.invernizzi01@universitadipavia.it.
Cinzia BoselliDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy. cinzia.boselli@unipv.it.ORCID 0000-0001-7637-7558
Antonia Icaro CornagliaDepartment of Public Health Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy. antonia.icaro@unipv.it.
Claudia Del FanteImmunohaematology and Transfusion Service and Cell Therapy Unit of Fondazione IRCCS, S. Matteo, 27100 Pavia, Italy. c.delfante@smatteo.pv.it.ORCID 0000-0003-0822-0342
Cesare PerottiImmunohaematology and Transfusion Service and Cell Therapy Unit of Fondazione IRCCS, S. Matteo, 27100 Pavia, Italy. c.perotti@smatteo.pv.it.
Barbara ViganiDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy. barbara.vigani@unipv.it.
Federica RivaDepartment of Public Health Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy. federica.riva01@unipv.it.ORCID 0000-0001-9000-1696
Carla CaramellaDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy. carla.caramella@unipv.it.
Franca FerrariDepartment of Drug Sciences, University of Pavia, 27100 Pavia, Italy. franca.ferrari@unipv.it.
University of Pavia · ITPoliclinico San Matteo Fondazione · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chitosan oleate was previously proposed to encapsulate in nanocarriers some poorly soluble molecules aimed to wound therapy, such as the anti-infective silver sulfadiazine, and the antioxidant α tocopherol. Because nanocarriers need a suitable formulation to be administered to wounds, in the present paper, these previously developed nanocarriers were loaded into freeze dried dressings based on chitosan glutamate. These were proposed as bioactive dressings aimed to support the application to wounds of platelet lysate, a hemoderivative rich in growth factors. The dressings were characterized for hydration capacity, morphological aspect, and rheological and mechanical behavior. Although chitosan oleate nanocarriers clearly decreased the mechanical properties of dressings, these remained compatible with handling and application to wounds. Preliminary studies in vitro on fibroblast cell cultures demonstrated good compatibility of platelet lysate with nanocarriers and bioactive dressings. An in vivo study on a murine wound model showed an accelerating wound healing effect for the bioactive dressing and its suitability as support of the platelet lysate application to wounds.

Indexed as

Biological Dressingsalpha-TocopherolAnimalsBlood PlateletsCell ProliferationChitosanDrug CarriersDrug CompoundingFibroblastsMaleNanostructuresOleic AcidRatsRats, WistarRheologySilver Sulfadiazinealpha-TocopherolChitosanDrug CarriersOleic AcidSilver SulfadiazineAg sulfadiazinechitosan oleatenanocarriersplatelet gelplatelet lysatewound healingα tocopherol

Identifiers

PMID29425164
PMCPMC5852484
OpenAlexW2791153355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.